arrow
A

Alberto Servetto

university of naples federico ii
H指数:23
被引数:2,232

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FGFR-Altered Urothelial Carcinoma in the EV–Pembrolizumab Era: Rationale and Emerging Data for Upfront Triplet Strategies

FGFR突变型尿路上皮癌在EV–帕博利珠单抗时代的治疗策略:早期三联疗法的合理性与新兴数据

2026-10-070
OAAI
MAP of molecular analyses in real-worlD oncology centers – MAPpaMoNDO: a study of the translational research Young GOIM group

现实世界肿瘤中心分子分析地图——MAPpaMoNDO:青年GOIM组转化研究的研究

2026-08-180
OA
RAS Inhibitors: Changing the Paradigm from the Undruggable

RAS抑制剂:改变不可成药靶点的范式

2026-07-280
OA
The impact of relative dose intensity on pathological complete response in neoadjuvant chemotherapy of muscle-invasive urothelial cancer: a multicenter retrospective study

相对剂量强度对肌肉浸润性尿路上皮癌新辅助化疗中病理完全缓解的影响:一项多中心回顾性研究

2026-07-020
OAAI
The Impact of Histology Subtype and Size of Giant Retroperitoneal Liposarcomas on Their Risk of Recurrence: A Retrospective Cohort Analysis

腹膜后巨大脂肪肉瘤的组织学亚型及大小对其复发风险的影响:一项回顾性队列分析

Cancers
IF4.4
2026-05-200
OA
Semen Analysis in Men with Testicular Cancer: Insights from a Large Fertility Preservation Cohort Toward Personalized Fertility Assessment

男性睾丸癌患者的精液分析:来自大型生育力保存队列对个性化生育力评估的启示

2026-05-190
OAAI
Salvage radiotherapy with or without hormonal therapy for biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis

根治性前列腺切除术后生化复发患者的挽救性放射治疗联合或不联合激素治疗:一项系统评价和Meta分析

2026-05-180
OAAI
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis

免疫疗法在晚期非小细胞肺癌III期试验中,ORR与PFS与OS结局的相关性:系统评价与Meta分析

2025-12-160
OAAI
Quality of Life results and survival outcomes in trials of immunotherapy in advanced cancers: a systematic review and meta-research study

生活质量结果和生存结局在晚期癌症免疫疗法试验中的研究:一项系统评价和元研究

2025-09-180
OAAI
Impact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis

铂类化疗和CTLA-4抑制对非小细胞肺癌中一线抗PD-1/PD-L1药物获得性耐药的影响:一项系统综述和重构的个体患者数据分析

2025-09-020
PREAI
Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis

评估内脏疾病患者中转移性激素敏感性前列腺癌的治疗效果:一项系统评价和网络Meta分析

2025-07-100
OAAI
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL

功能性呼吸测试在III期NSCLC患者接受化疗、放疗和免疫治疗时预测肺毒性的作用:PRELUDIO试验

2025-06-060
PRE
Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis

新辅助与围手术期化免疫疗法根据病理反应在可切除非小细胞肺癌中的比较:一项重构的个体患者数据meta分析

2025-06-011
PRE
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors

AP1介导的EGFR表达重编程触发了RET易位肿瘤对BLU-667和LOXO-292的耐药性

2025-05-220
OA
Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients

向抗PD-1/PD-L1药物中添加二甲双胍可激活NSCLC患者外周免疫细胞的抗肿瘤免疫应答

2025-04-130
OA